Royal Bank of Canada’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$552K Buy
+243,547
New +$552K ﹤0.01% 4065
2024
Q3
Sell
-248
Closed 6458
2024
Q2
$0 Buy
+248
New ﹤0.01% 6688
2024
Q1
Sell
-798
Closed -$1K 6594
2023
Q4
$1K Buy
+798
New +$1K ﹤0.01% 6363
2023
Q3
Sell
-484
Closed -$1K 6623
2023
Q2
$1K Buy
484
+384
+384% +$793 ﹤0.01% 6521
2023
Q1
$0 Hold
100
﹤0.01% 6697
2022
Q4
$0 Sell
100
-177
-64% ﹤0.01% 6798
2022
Q3
$0 Buy
277
+177
+177% ﹤0.01% 6984
2022
Q2
$0 Sell
100
-3,985
-98% ﹤0.01% 6919
2022
Q1
$11K Sell
4,085
-10,927
-73% -$29.4K ﹤0.01% 6412
2021
Q4
$64K Buy
15,012
+8,350
+125% +$35.6K ﹤0.01% 5693
2021
Q3
$35K Buy
6,662
+1,122
+20% +$5.9K ﹤0.01% 5838
2021
Q2
$35K Buy
5,540
+1,532
+38% +$9.68K ﹤0.01% 5760
2021
Q1
$31K Buy
4,008
+3,908
+3,908% +$30.2K ﹤0.01% 5680
2020
Q4
$1K Sell
100
-65
-39% -$650 ﹤0.01% 6373
2020
Q3
$1K Sell
165
-112
-40% -$679 ﹤0.01% 5911
2020
Q2
$3K Sell
277
-51
-16% -$552 ﹤0.01% 5691
2020
Q1
$3K Sell
328
-614
-65% -$5.62K ﹤0.01% 5671
2019
Q4
$8K Buy
942
+842
+842% +$7.15K ﹤0.01% 5608
2019
Q3
$1K Hold
100
﹤0.01% 5748
2019
Q2
$1K Hold
100
﹤0.01% 5717
2019
Q1
$1K Hold
100
﹤0.01% 5603
2018
Q4
$2K Sell
100
-1,141
-92% -$22.8K ﹤0.01% 5538
2018
Q3
$23K Buy
1,241
+957
+337% +$17.7K ﹤0.01% 4993
2018
Q2
$6K Buy
+284
New +$6K ﹤0.01% 5391
2018
Q1
Sell
-307
Closed -$6K 5744
2017
Q4
$6K Sell
307
-2,165
-88% -$42.3K ﹤0.01% 5271
2017
Q3
$45K Buy
2,472
+2,427
+5,393% +$44.2K ﹤0.01% 4740
2017
Q2
$1K Sell
45
-682
-94% -$15.2K ﹤0.01% 5617
2017
Q1
$13K Sell
727
-136
-16% -$2.43K ﹤0.01% 5152
2016
Q4
$9K Buy
+863
New +$9K ﹤0.01% 5350